Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acadia Pharmaceutica (NQ: ACAD )

20.39 USD -0.29 (-1.40%)
Official Closing Price Updated: 7:57 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Acadia Pharmaceutica

< Previous 1 2 3 4 5 6 7 8 9
...
82 83 Next >
The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
Contrary to the strength in the broader market, biotech stocks ended the week ending April 9 lower. The weakness partly reflected a ... 
Tags ANX TIL MRTX
From Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 13 companies achieved new lows for the year. Intriguing Points: The largest company by ... 
Tags Markets Intraday Update ELP
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2021
Upgrades According to Janney Capital, the prior rating for Texas Capital Bancshares Inc (NASDAQ:TCBI) was changed from ... 
Tags LBPH WM SAIA
From Benzinga
10 Biggest Price Target Changes For Wednesday
Keybanc raised Applied Materials, Inc. (NASDAQ: AMAT) price target from $144 to $151. Applied Materials shares rose 0.1% to $139.65 ... 
Tags AMAT DISCA MAXN
From Benzinga
The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Small Cap AZN CARA
From Benzinga
After FDA Rejects Acadia Dementia Drug, Analysts Lament Lack Of Near-term Stock Drivers
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares came under pressure Monday after theFood and Drug Administration (FDA) ... 
Tags Reiteration ACAD FDA
From Benzinga
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Acadia Pharmaceuticals (ACAD) For Possible Securities Law Violations, Encourages Investors with Losses to Contact Its Attorneys
From GlobeNewswire News Releases
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2021
Upgrades Craig-Hallum upgraded the previous rating for BBQ Holdings Inc (NASDAQ:BBQ) from Hold to Buy. BBQ Hldgs earned ... 
Tags LBPH YUMC YUM
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Before 10 a.m. ET Tuesday, 6 stocks made new 52-week lows. Highlights: Nikola (NASDAQ:NKLA) was the biggest ... 
Tags MTCR IMRA Benzinga
From Benzinga
The Daily Biotech Pulse: Illumina Lights Up, Cara Soars On Index Inclusion, Novavax Starts Crossover Vaccine Study, Turning Point Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Offerings IBB DVAX
From Benzinga
10 Biggest Price Target Changes For Tuesday
Evercore ISI Group cut Peloton Interactive, Inc. (NASDAQ: PTON) price target from $160 to $125. Peloton Interactive shares fell 0.4% ... 
Tags Price Target Changes PFSI Analyst Ratings
From Benzinga
54 Biggest Movers From Yesterday
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares climbed 60.2% to close at $5.64 on Monday after the company announced the ... 
Tags Trading Ideas GBOX PLBY
From Benzinga
Ademi LLP Investigates Claims of Securities Fraud against Acadia Pharmaceuticals Inc.
Ademi LLP is investigating possible securities fraud claims against Acadia (NASDAQ: ACAD). The investigation results from inaccurate statements Acadia may have made regarding its financial results,... 
From PR Newswire
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Acadia Pharmaceuticals (ACAD) For Possible Securities Law Violations, Encourages Investors with Losses to Contact Its Attorneys
Hagens Berman invites Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain... 
From PR Newswire
Mid-Afternoon Market Update: Crude Oil Down 4.5%; Chembio Diagnostics Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 1.18% to 33,542.88 while the NASDAQ rose 1.7% to 13,709.47. The S&P also rose, ... 
Tags Markets Small Cap BVH
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Chembio Diagnostics (NASDAQ:CEMI) stock moved upwards by 58.52% to $5.58 during Monday's regular session. As ... 
Tags IPA POAI BZI/TFM
From Benzinga
Mid-Day Market Update: Leaf Group Jumps Following Acquisition News; ACADIA Pharmaceuticals Shares Slide
Midway through trading Monday, the Dow traded up 1.16% to 33,536.76 while the NASDAQ rose 1.37% to 13,664.49. The S&P also rose, ... 
Tags Penny Stocks ACAD Benzinga
From Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) jumped 46% to $5.14 after the company announced the commercial launch of a test ... 
Tags Information Technology Top Gainers EEIQ
From Benzinga
Acadia Stock Crashes After FDA Rejects Key Drug — Analyst Sees Huge Delay
The Food and Drug Administration rejected Acadia Pharma's Nuplazid for patients with dementia-related psychosis on Monday, leading ACAD stock to plunge to its lowest point in two years. 
From Investor's Business Daily
Why ACADIA Pharmaceuticals's Stock is Trading Lower Today
ACADIA Pharmaceuticals's Stock Price And Volume Action ACADIA Pharmaceuticals's (NASDAQ:ACAD) stock has been falling Monday, ... 
Tags Movers Market News BZI/WIIM
From Benzinga
Mid-Morning Market Update: Markets Open Higher; ISM Services PMI Surges To Record High
Following the market opening Monday, the Dow traded up 0.87% to 33,441.43 while the NASDAQ rose 1.05% to 13,621.94. The S&P also ... 
Tags NNOX LEAF TH
From Benzinga
Stocks That Hit 52-Week Lows On Monday
Before 10 a.m. ET on Monday, 3 companies set new 52-week lows. Areas of Interest: Cia Paranaense De Energia ... 
Tags 52 Week Lows Trading Ideas Movers
From Benzinga
Why Acadia Pharma, Bio-path And Cidara Are Moving Today
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), Bio-Path Holdings, Inc. (NASDAQ: BPTH) and Cidara Therapeutics, Inc. (NASDAQ: CDTX) are ... 
Tags BPTH News Trading Ideas
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Chembio Diagnostics (NASDAQ:CEMI) shares rose 47.29% to $5.17 during Monday's pre-market session. The market ... 
Tags CTIC ACAD Benzinga
From Benzinga
Acadia Stock Drops After FDA CRL For Pimavanserin Application In Hallucinations and Dementia-Related Psychosis
TheFDA has issued a Complete Response Letter(CRL) toAcadia Pharmaceuticals Inc(NASDAQ:ACAD) regarding ... 
Tags News Health Care Psychosis
From Benzinga
Acadia Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Dementia
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its supplemental New... 
From Business Wire News Releases
These 2 Scrappy Biotechs Could Skyrocket in April
They've both taken a beating, but their fortunes may soon change. 
Tags Market News SUPN ACAD
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
A slew of drugs, including four new molecular entities, were approved in the month of March. NMEs are drugs that contain active moieties ... 
Tags TMDX SNY ATXI
From Benzinga
The Week Ahead In Biotech (March 28-April 3): Acadia's Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week
Biotech stocks reversed course and ended lower in the week ended March 26, drawing inspiration from the broader market weakness. The ... 
Tags BIOC IBB SAGE
From Benzinga
Implied RYJ Analyst Target Price: $67
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
82 83 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback